Interact to see
Advertisement
Advertisement
JVMSX vs MCVAX
JVMSX vs MCVAX Comparison
Open Charts JVMSX vs MCVAX
JHancock Disciplined Value Mid Cap R2
Price$29.91
Change-$0.08 (-0.27%)
VolumeN/A
Net Assets24.35B
Transamerica Mid Cap Value Opps A
Price$11.42
Change-$0.02 (-0.17%)
VolumeN/A
Net Assets979.49M
JVMSX vs MCVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
JVMSX vs. MCVAX commentary
Sep 17, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMSX is a Buy and MCVAX is a Buy.
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 24.3B vs. MCVAX (979M). MCVAX pays higher dividends than JVMSX: MCVAX (1.01) vs JVMSX (0.40). JVMSX was incepted earlier than MCVAX: JVMSX (14 years) vs MCVAX (11 years). JVMSX (1.25) and MCVAX (1.19) have similar cost to investors . JVMSX (49.00) and MCVAX (48.00) have comparable annual turnover. JVMSX has a lower initial minimum investment than MCVAX: JVMSX (0) vs MCVAX (1000). JVMSX annual gain was more profitable for investors over the last year : 0.85 vs. MCVAX (-1.05). JVMSX return over 5 years is better than : 52.20 vs. MCVAX (14.55).
| JVMSX | MCVAX | JVMSX / MCVAX | |
| Total Expense Ratio | 1.24 | 1.19 | 104% |
| Annual Report Gross Expense Ratio | 1.25 | 1.19 | 105% |
| Fund Existence | 14 years | 11 years | - |
| Gain YTD | 11.861 | 8.333 | 142% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 24.3B | 979M | 2,482% |
| Annual Yield % from dividends | 0.40 | 1.01 | 40% |
| Returns for 1 year | 0.85 | -1.05 | -80% |
| Returns for 3 years | 24.57 | 5.66 | 434% |
| Returns for 5 years | 52.20 | 14.55 | 359% |
| Returns for 10 years | 56.05 | 9.00 | 623% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement